MedPath

Clinical effect evaluation of Guben Qushi Prescription in treating dampness of spleen deficiency eczema

Phase 1
Not yet recruiting
Conditions
Eczema
Registration Number
ITMCTR2200006104
Lead Sponsor
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Meet the diagnostic criteria of Western medicine for eczema;
(2) Conforms to the diagnostic criteria of spleen deficiency and dampness accumulation syndrome of TRADITIONAL Chinese medicine (determined by combining the industry standards of TRADITIONAL Chinese medicine and the preliminary research results of the research group);
(3) Age: 18-65;
(4) 7 < eczema area and severity index (EASI) =21;
(5) skin area =3% (3% is equivalent to 3 palm area);
(6) Voluntarily participate in the study and sign the informed consent.

Exclusion Criteria

(1) Patients with abnormal blood system, liver, kidney, heart and other systems;
(2) patients suffering from mental diseases, malignant tumors, diabetes and heart disease, and pregnant and lactating women;
(3) with other skin diseases;
(4) Systematic use of glucocorticoids or immunosuppressants (including Tripterygium wilfordii) in the last 4 weeks;
(5) known allergic to test drug components.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.